GR78667B - - Google Patents
Info
- Publication number
- GR78667B GR78667B GR72231A GR830172231A GR78667B GR 78667 B GR78667 B GR 78667B GR 72231 A GR72231 A GR 72231A GR 830172231 A GR830172231 A GR 830172231A GR 78667 B GR78667 B GR 78667B
- Authority
- GR
- Greece
- Prior art keywords
- compounds
- formulawhere
- benzodioxepin
- prepar
- antihypertensive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/410,155 US4405631A (en) | 1982-08-20 | 1982-08-20 | Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'pyrrolidine] compounds and their use as antihypertensive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GR78667B true GR78667B (el) | 1984-09-27 |
Family
ID=23623465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR72231A GR78667B (el) | 1982-08-20 | 1983-08-17 |
Country Status (20)
Country | Link |
---|---|
US (1) | US4405631A (el) |
EP (1) | EP0102034B1 (el) |
JP (1) | JPS5953489A (el) |
KR (1) | KR840005729A (el) |
AT (1) | ATE33656T1 (el) |
AU (1) | AU576473B2 (el) |
CA (1) | CA1210764A (el) |
DE (1) | DE3376327D1 (el) |
DK (1) | DK381983A (el) |
ES (2) | ES8505685A1 (el) |
FI (1) | FI832959A (el) |
GR (1) | GR78667B (el) |
HU (1) | HU191874B (el) |
IL (1) | IL69525A0 (el) |
MA (1) | MA19881A1 (el) |
NO (1) | NO833001L (el) |
NZ (1) | NZ205320A (el) |
PH (1) | PH18839A (el) |
PT (1) | PT77223B (el) |
ZA (1) | ZA836127B (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4521537A (en) * | 1982-08-20 | 1985-06-04 | Hoechst-Roussel Pharmaceuticals Incorporated | Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidine] compounds and their use as antihypertensive agents |
US4472580A (en) * | 1982-08-20 | 1984-09-18 | Hoechst-Roussel Pharmaceuticals Incorporated | Spiro (2H-1,4-benzodioxepin-3 (5H)4-piperidine and -3-pyrrolidine) compounds and their use as anti-hypertensive agents |
US4751223A (en) * | 1986-10-14 | 1988-06-14 | Hoechst-Roussel Pharmaceuticals, Inc. | Antiinflammatory and analgesic aminoalkyl tetracyclic benzodiazepines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1312894A (fr) * | 1962-01-29 | 1962-12-21 | Geigy Ag J R | Nouveaux composés hétérocycliques à 2 atomes d'oxygène dans le cycle et leur préparation |
CH469736A (de) * | 1966-06-28 | 1969-03-15 | Geigy Ag J R | Verfahren zur Herstellung von neuen Heterospiroalkanen |
US3679666A (en) * | 1969-04-03 | 1972-07-25 | Hoffmann La Roche | 4-(4-hydroxypiperidino)-4'-fluorobutyrophenones |
-
1982
- 1982-08-20 US US06/410,155 patent/US4405631A/en not_active Expired - Fee Related
-
1983
- 1983-08-17 GR GR72231A patent/GR78667B/el unknown
- 1983-08-18 KR KR1019830003853A patent/KR840005729A/ko not_active Application Discontinuation
- 1983-08-18 NZ NZ205320A patent/NZ205320A/en unknown
- 1983-08-18 ES ES525013A patent/ES8505685A1/es not_active Expired
- 1983-08-18 EP EP83108156A patent/EP0102034B1/en not_active Expired
- 1983-08-18 FI FI832959A patent/FI832959A/fi not_active Application Discontinuation
- 1983-08-18 AT AT83108156T patent/ATE33656T1/de not_active IP Right Cessation
- 1983-08-18 DE DE8383108156T patent/DE3376327D1/de not_active Expired
- 1983-08-18 PH PH29413A patent/PH18839A/en unknown
- 1983-08-19 AU AU18169/83A patent/AU576473B2/en not_active Ceased
- 1983-08-19 PT PT77223A patent/PT77223B/pt unknown
- 1983-08-19 HU HU832920A patent/HU191874B/hu unknown
- 1983-08-19 NO NO833001A patent/NO833001L/no unknown
- 1983-08-19 ZA ZA836127A patent/ZA836127B/xx unknown
- 1983-08-19 JP JP58150473A patent/JPS5953489A/ja active Pending
- 1983-08-19 DK DK381983A patent/DK381983A/da not_active Application Discontinuation
- 1983-08-19 IL IL69525A patent/IL69525A0/xx unknown
- 1983-08-19 CA CA000434928A patent/CA1210764A/en not_active Expired
- 1983-08-20 MA MA20103A patent/MA19881A1/fr unknown
-
1985
- 1985-03-01 ES ES540841A patent/ES8602800A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0102034B1 (en) | 1988-04-20 |
FI832959A0 (fi) | 1983-08-18 |
NZ205320A (en) | 1987-05-29 |
ES540841A0 (es) | 1985-12-01 |
CA1210764A (en) | 1986-09-02 |
AU576473B2 (en) | 1988-09-01 |
ATE33656T1 (de) | 1988-05-15 |
ES525013A0 (es) | 1985-06-01 |
PT77223A (en) | 1983-09-01 |
DK381983A (da) | 1984-02-21 |
FI832959A (fi) | 1984-02-21 |
ES8505685A1 (es) | 1985-06-01 |
KR840005729A (ko) | 1984-11-16 |
ZA836127B (en) | 1984-04-25 |
PH18839A (en) | 1985-10-10 |
PT77223B (en) | 1986-03-18 |
MA19881A1 (fr) | 1984-04-01 |
US4405631A (en) | 1983-09-20 |
AU1816983A (en) | 1984-02-23 |
DK381983D0 (da) | 1983-08-19 |
HU191874B (en) | 1987-04-28 |
NO833001L (no) | 1984-02-21 |
JPS5953489A (ja) | 1984-03-28 |
IL69525A0 (en) | 1983-11-30 |
DE3376327D1 (en) | 1988-05-26 |
EP0102034A1 (en) | 1984-03-07 |
ES8602800A1 (es) | 1985-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL314086A1 (en) | Novel (r)-8-fluoro-3-n,n-substituted amino 3,4-dihydro 5-carbamoyl-2h-1-bezopyranes | |
JO1502B1 (en) | New pharmacy vehicles | |
IL125282A (en) | Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases | |
EG18379A (en) | Novel pharmacological compounds | |
ES8802386A1 (es) | Procedimiento para prepara (1,2,4)-triazolo (1,5-c)quinazolinas | |
GB8518658D0 (en) | Medicaments | |
IL76456A (en) | 1-substituted tetralin derivatives,their preparation and pharmaceutical compositions containing them | |
HUT38097A (en) | Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances | |
ES8607299A1 (es) | Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas | |
GR78667B (el) | ||
MY106961A (en) | Antiviral tetrahydroimidazo[1,4] benzodiazepines | |
MY106292A (en) | (alpha)-adrenergic receptor antagonists. | |
JO1531B1 (en) | New near-compounds |